PharVision Advisers’s Avis CAR Stock Holding History

PharVision Advisers’s Portfolio CAR Stock Details CAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,169	Closed	-$407K	–	182
2025 Q4	$407K	Buy	+3,169	New	+$442K	0.21%	116

Other funds holding CAR

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PharVision Advisers's CAR Position: Q1 2026 in Review

PharVision Advisers sold out of Avis (CAR) in Q1 2026, closing a stake of 3,169 shares — an estimated $407K sold.

PharVision Advisers first reported a position in CAR in Q4 2025 and held it in 1 quarter. The position peaked at $407K in Q4 2025. 291 funds tracked by Wall St. Rank hold CAR as of Q1 2026.

PharVision Advisers reported no remaining Avis position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,169 Avis shares in Q1 2026, an estimated $407K.
PharVision Advisers first reported a position in Avis in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Avis position peaked at $407K in Q4 2025.
291 funds tracked by Wall St. Rank held Avis as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.